Biogen plans late-stage trial for Alzheimer's treatment
Tuesday, December 2, 2014 - 12:00
in Health & Medicine
(Reuters) - Biogen Idec Inc's research chief on Tuesday said the company was planning a late-stage trial of its experimental treatment for Alzheimer's disease after the drug cut brain plaque levels and improved cognition in a small early-stage study.